About Index Trending news
Analyze
Pricing
Epic Sciences

Epic Sciences

Work at Epic Sciences? Add yourself to this profile

Epic Sciences

Developing new diagnostic blood tests that can identify and characterize circulating tumor cells to improve cancer detection and to personalize medicine.

Elsewhere

Contributors to this profile

Alexa global traffic share

Twitter followers

28 Apr 2017
$40,000,000
Venture capital (Series D)
Domain Associates, Genomic Health, Sabby Capital, +6

Epic Sciences takes in $40 mln Series D

PE Hub
01 Jun 2015
$15,000,000
Debt financing
30 Jul 2014
$30,000,000
Venture capital (Series C)
Domain Associates, Roche Venture Fund, Arcus Ventures, +2
13 Nov 2012
$13,000,000
Venture capital (Series B)
Domain Associates, Roche Venture Fund, Pfizer Venture Investments